107 related articles for article (PubMed ID: 25398847)
1. PIK3CA mutational status in circulating tumor cells can change during disease recurrence or progression in patients with breast cancer.
Markou A; Farkona S; Schiza C; Efstathiou T; Kounelis S; Malamos N; Georgoulias V; Lianidou E
Clin Cancer Res; 2014 Nov; 20(22):5823-34. PubMed ID: 25398847
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of circulating tumor cell numbers improves tracking metastatic breast cancer progression.
Szostakowska-Rodzos M; Fabisiewicz A; Wakula M; Tabor S; Szafron L; Jagiello-Gruszfeld A; Grzybowska EA
Sci Rep; 2024 Jun; 14(1):12924. PubMed ID: 38839863
[TBL] [Abstract][Full Text] [Related]
3. Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood.
Higgins MJ; Jelovac D; Barnathan E; Blair B; Slater S; Powers P; Zorzi J; Jeter SC; Oliver GR; Fetting J; Emens L; Riley C; Stearns V; Diehl F; Angenendt P; Huang P; Cope L; Argani P; Murphy KM; Bachman KE; Greshock J; Wolff AC; Park BH
Clin Cancer Res; 2012 Jun; 18(12):3462-9. PubMed ID: 22421194
[TBL] [Abstract][Full Text] [Related]
4. Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer.
Kodahl AR; Ehmsen S; Pallisgaard N; Jylling AMB; Jensen JD; Laenkholm AV; Knoop AS; Ditzel HJ
Mol Oncol; 2018 Jun; 12(6):925-935. PubMed ID: 29689598
[TBL] [Abstract][Full Text] [Related]
5. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.
Yu M; Bardia A; Aceto N; Bersani F; Madden MW; Donaldson MC; Desai R; Zhu H; Comaills V; Zheng Z; Wittner BS; Stojanov P; Brachtel E; Sgroi D; Kapur R; Shioda T; Ting DT; Ramaswamy S; Getz G; Iafrate AJ; Benes C; Toner M; Maheswaran S; Haber DA
Science; 2014 Jul; 345(6193):216-20. PubMed ID: 25013076
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients.
Keup C; Suryaprakash V; Storbeck M; Hoffmann O; Kimmig R; Kasimir-Bauer S
Cells; 2021 Jan; 10(2):. PubMed ID: 33494385
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms.
Paoletti C; Cani AK; Larios JM; Hovelson DH; Aung K; Darga EP; Cannell EM; Baratta PJ; Liu CJ; Chu D; Yazdani M; Blevins AR; Sero V; Tokudome N; Thomas DG; Gersch C; Schott AF; Wu YM; Lonigro R; Robinson DR; Chinnaiyan AM; Bischoff FZ; Johnson MD; Park BH; Hayes DF; Rae JM; Tomlins SA
Cancer Res; 2018 Feb; 78(4):1110-1122. PubMed ID: 29233927
[TBL] [Abstract][Full Text] [Related]
8. Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations.
Miranda AX; Kemp J; Davidson BA; Bellomo SE; Miranda VE; Manoni A; Marchiò C; Croessmann S; Park BH; Hodges E
BMC Genomics; 2024 May; 25(1):519. PubMed ID: 38802751
[TBL] [Abstract][Full Text] [Related]
9. Pathway-driven discovery of rare mutational impact on cancer.
Ahn T; Park T
Biomed Res Int; 2014; 2014():171892. PubMed ID: 24883302
[TBL] [Abstract][Full Text] [Related]
10. The Discordance of Gene Mutations between Circulating Tumor Cells and Primary/Metastatic Tumor.
Wang Q; Zhao L; Han L; Tuo X; Ma S; Wang Y; Feng X; Liang D; Sun C; Wang Q; Song Q; Li Q
Mol Ther Oncolytics; 2019 Dec; 15():21-29. PubMed ID: 31650022
[TBL] [Abstract][Full Text] [Related]
11. Advancing Circulating Tumor DNA for Recurrent Breast Cancer.
Di Cosimo S; Cappelletti V; Pruneri G
JCO Precis Oncol; 2023 Jan; 7():e2200596. PubMed ID: 36701652
[No Abstract] [Full Text] [Related]
12. Metastatic progression of breast cancer along with decreased mitochondrial cell death priming of breast cancer cells: a case report.
Aka Y; Ozdemir H; Torun N; Bolat FA; Kutuk O
Oxf Med Case Reports; 2024 Mar; 2024(3):omae014. PubMed ID: 38532756
[TBL] [Abstract][Full Text] [Related]
13. What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-Mutated Tumors? Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland.
Pretzell I; Desuki A; Bleckmann A; Loges S; Reinacher-Schick A; Westphalen CB; Lange S;
Oncol Res Treat; 2024 May; ():1-9. PubMed ID: 38714183
[TBL] [Abstract][Full Text] [Related]
14. Biology, detection, and clinical implications of circulating tumor cells.
Joosse SA; Gorges TM; Pantel K
EMBO Mol Med; 2015 Jan; 7(1):1-11. PubMed ID: 25398926
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of circulating tumor cells in breast cancer.
Fina E; Callari M; Reduzzi C; D'Aiuto F; Mariani G; Generali D; Pierotti MA; Daidone MG; Cappelletti V
Clin Chem; 2015 Jan; 61(1):278-89. PubMed ID: 25411184
[TBL] [Abstract][Full Text] [Related]
16. NanoFlares for the detection, isolation, and culture of live tumor cells from human blood.
Halo TL; McMahon KM; Angeloni NL; Xu Y; Wang W; Chinen AB; Malin D; Strekalova E; Cryns VL; Cheng C; Mirkin CA; Thaxton CS
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17104-9. PubMed ID: 25404304
[TBL] [Abstract][Full Text] [Related]
17. Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor.
Juric D; Castel P; Griffith M; Griffith OL; Won HH; Ellis H; Ebbesen SH; Ainscough BJ; Ramu A; Iyer G; Shah RH; Huynh T; Mino-Kenudson M; Sgroi D; Isakoff S; Thabet A; Elamine L; Solit DB; Lowe SW; Quadt C; Peters M; Derti A; Schegel R; Huang A; Mardis ER; Berger MF; Baselga J; Scaltriti M
Nature; 2015 Feb; 518(7538):240-4. PubMed ID: 25409150
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patients.
Pantel K; Alix-Panabières C
Bonekey Rep; 2014; 3():584. PubMed ID: 25419458
[TBL] [Abstract][Full Text] [Related]
19. In vitro culturing of viable circulating tumor cells of urinary bladder cancer.
Cegan M; Kolostova K; Matkowski R; Broul M; Schraml J; Fiutowski M; Bobek V
Int J Clin Exp Pathol; 2014; 7(10):7164-71. PubMed ID: 25400813
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling of circulating tumor cells in metastatic breast cancer.
Lang JE; Scott JH; Wolf DM; Novak P; Punj V; Magbanua MJ; Zhu W; Mineyev N; Haqq CM; Crothers JR; Esserman LJ; Tripathy D; van 't Veer L; Park JW
Breast Cancer Res Treat; 2015 Jan; 149(1):121-31. PubMed ID: 25432738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
